blogs created to prevent or detect a crime

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime

Friday, 30 December 2011

Mary Johnson an ex-scientologist who had sued the Irish wing of Scientology - RTE video on FIDDAMAN blog

Uploaded by AnonPaddy on 2 Jul 2009

Late Late show hosted by the one and only Gay Burn, who did an episode that talked about Scientology.

This episode had Mary Johnson an ex-scientologist as a guest who had sued the Irish wing of Scientology due to psychiatric and psychological injuries and post traumatic stress disorder that she suffered in Scientology.

Brainwashed Irish woman sues Scientology cult - RTE News (2002): "Dublin woman sues Scientology church"

RTE News (2002): "Dublin woman sues Scientology church"

«A Dublin woman who claims she was controlled by a cult has begun a High Court legal action for damages.

40-year-old sports shop owner Mary Johnson from Westwood, Foxrock, was a member of the Church of Scientology for two years between 1992 and 1994.

She is now suing the organisation because of the experiences and pressures she claims she suffered while a member and the threats and intimidation when she tried to leave.»

The Irish Examiner (2002): "Woman was 'psychologically injured'" by Vivion Kilfeather

«A woman who claims she was brainwashed by the Church of Scientology is suing for damages. Dundalk-born Mary Johnson, 40, who has a sports equipment shop at Westwood, Foxrock, is also suing three members of the church: John Keane, Tom Cunningham and Gerard Ryan.

In the High Court yesterday, Sean Ryan SC for Ms Johnson, said she was "sucked in" by the organisation which brought her under its control and influence.

She was recruited to the church in 1992. Efforts were made to prevent her leaving the organisation, to silence her and to devalue her. The court was also told efforts had been made to intimidate her and to prevent her suing.

Mr Ryan said the court would be introduced to a language of psycho religious-mythical scope and expressions and words with no meaning other than being defined as Scientology.

Ms Johnson had suffered psychological, psychiatric injuries, panic attacks and post traumatic stress disorder, together with loss of short term memory and that condition had been exacerbated by the subsequent illegitimate conduct of the defendants.»

Irish Times (2002): "Scientology case woman tells of abortion confession"

«A woman who is suing the Church of Scientology told the High Court yesterday she became very distressed during a church "auditing session" in 1992 and had recounted an event that nobody else knew about her, that she had been pregnant and had had an abortion.

Ms Mary Johnston, who has a sports shop in Foxrock, Co Dublin, was giving evidence on the second day of her action against the Church of Scientology Mission of Dublin Ltd and three of its members: John Keane, Tom Cunningham and Gerard Ryan.

She is seeking damages under a number of headings, including conspiracy, misrepresentation and breach of constitutional rights.

Yesterday Ms Johnston (40) said she had had a number of auditing sessions with Mr Cunningham from late 1991. At one session in January 1992 she was unable to recall anything.

Mr Cunningham had told her there "must be something". She ultimately remembered the one thing in the world that nobody knew about her and said she wanted to stop the session.»

Irish Times (2002): "Church pressed woman to sell shop, court told"

«"By the time they had finished with me after five hours had elapsed, I had agreed I was going to sell my business. I was elated," she said. She tried to borrow from her boyfriend at the time, who turned down her request.

As a result of her involvement with the church, she became withdrawn from her family and friends. She tried to recruit people into scientology but was unsuccessful in most cases. She had many rows with her boyfriend in which she "screamed, shouted, ranted and raved". Her short-term memory started to be affected.

Ms Johnston is suing the Church of Scientology Mission of Dublin Ltd and three of its members, Mr John Keane, Mr Tom Cunningham and Mr Gerard Ryan, for alleged conspiracy, misrepresentation and breach of constitutional rights.

Earlier, Ms Johnston said she was told she could not read an article in the Evening Herald which was critical of scientology. She had heard the article had made reference to a person who had left Scientology in California. The article also made reference to Tom Cruise and Nicole Kidman having been visitors to that place.»

Irish Times (2002): "Woman suing Scientologists feared private life would be made public"

«From May 1994, having left Scientology, Ms Johnston said she lived in dread and fear because she knew what she had told the movement in confidence "risked being breached". She believed her private life in some way was going to become public.

Towards October, she began to have very bad and prolonged headaches and was dizzy. She went to a doctor. She linked the headaches to Scientology.

She was invited to speak at a meeting in Clonliffe College in late 1994. Afterwards, a letter was sent by Mr Gerard Ryan to Stephen O'Brien, a journalist then with the Irish Independent. The letter came into her possession shortly afterwards. When she read it she was gutted because she knew then that the fears she had were well founded. She was grieved by what she read and she also felt betrayed.»

Irish Times (2002): "Church of Scientology 'coercive'"

«Ms Johnston said she felt she had carried out things on a human being without having had the medical background to do so. She had done this through following the commands given by L. Ron Hubbard, the founder of the church.

Asked about carrying placards outside a Church of Scientology meeting, Ms Johnston said she believed the church was coercive and destructive and altered people's perception of reality.

"I defend people's rights to believe what they like, but if people carry out acts which harm people by taking them away from their families, then I have a problem with that and have a duty to speak."»

Irish church of Scientology in financial meltdown - another failure worthy of FIDDAMAN

REVENUES HAVE plummeted at the Irish branch of the controversial Church of Scientology, which remains deep in the red.

Membership of the worldwide church, established in 1954, includes movie stars such as Tom Cruise and John Travolta.

However, documents show that interest-free loans from abroad are propping up the Irish branch, which is more than €688,000 in the red in its latest accounts.

According to financial documents lodged by the Church of Scientology Mission of Dublin Ltd, the company’s revenues more than halved from €484,070 to €193,509 in 2009.

As a result of this 60 per cent drop, the church’s operating surplus fell 74 per cent, from €271,804 to €68,292.

The accounts are for the 12-month period to the end of April 2009, but were only signed off by the board on July 20th last after a long delay by the company in lodging the return.

The last occasion the company filed accounts was in October 2008.

Last night the non-executive director of the Church of Scientology Mission of Dublin, Gerard Ryan, blamed the recession for the drop in revenues. “We are not immune to the economic circumstances of the wider community and clearly this has impacted on our fundraising efforts,” he said.

Mr Ryan said the church “raises funds by the sale of our scriptures in the form of books, audio recordings and DVDs. We also raise funds via the extensive study courses in our scriptures that we provide, and the spiritual counselling that lies at the heart of our practice.”

He said the church’s numbers in Ireland were “difficult to quantify, but it is several hundred, and there are more than last year”.

Mr Ryan said the accumulated deficit “is largely due to a legal case some time back which lasted several years. We have been reducing the deficit year by year, and we expect to continue to do so.”

He added: “I’m very confident that this can be continued.”

Asked how the church performed from a financial point of view in 2010, Mr Ryan declined to say, stating that the accounts for 2010 were still not finalised.

The Irish branch is part of a global movement established by deceased US author L Ron Hubbard. It has more than 9,000 churches, missions and affiliated groups in 165 countries.

Scientologists believe Hubbard discovered the fundamental truths of existence and they revere him as “the source” of the religion.

Mr Ryan said: “I strongly believe that our church will continue to grow, both in Ireland and worldwide . . . Our growth in Ireland has been slow but steady, which is understandable in such an overwhelmingly Judaeo-Christian country.”

Hubbard established a Dublin mission in 1958, but it closed in the early 1960s. However, in the early 1990s, Scientology established its current Irish base on Middle Abbey Street in Dublin.

The movement’s directors, Ann-Marie Ryan, Siobhán Ryan and Gerard Ryan, confirm that “the deficit has been funded by loans from members of the Church of Scientology worldwide and other Church of Scientology missions”.

The directors state that as there are no fixed repayment arrangements on the interest-free loans, they “will be repaid at the discretion of the directors when future cash resources permit, which in turn is dependent on generating future surpluses”.

Tuesday, 27 December 2011

Klinefelter's. Syndrome - free E Book - KS Story has been compiled by a person with Klinefelter's. Syndrome

download here -

The following is a book written by Iain McKinley. Iain is an adult with Klinefelter Syndrome who was diagnosed in the late 1990's and began the journey of writing a book about Klinefelter Syndrome. Please read this letter first which describes the content of the book.

The book is quite a nice compilation of information that the author has compiled not only over the past 12 years since his diagnosis occurred, but a lot of information throughout his life. Please enjoy reading this book and if you'd like, send an email with your comments to the author, Iain McKinlay.

Please note, the book link below will attempt to download almost an 8 MB PDF file. The book 88 pages in a PDF format. If you do not have a high speed internet connection, this may take a long time to download.

Scientology & Lexapro withdrawal suicide suit - how KYLE THOMAS BRENNAN father was handled by the FIDDAMAN cult

Thomas Brennan Suicide - Scientology & SSRI Lexapro withdrawal - court documents FIDDAMAN blog reveal

Saturday, 24 December 2011

The Death of KYLE BRENNAN - Scientology Sued for Wrongful Death - FIDDAMAN cult is dangerous

"According to a complaint filed in Florida federal court, an adult son, Kyle Brennan, visits his Scientologist father and he has with him a prescription to Lexapro for depression and social anxiety. The Scientologist father lives in a complex with other Scientologists and the father is instructed by a church chaplain to take away the sons Lexapro so he locks the medication in his truck. On February 16th with ready access to a loaded gun, the son shot himself in the head."

Here are more details:

Kyle Brennan was born in Virginia in 1986 and was baptized a Catholic.

He was buried a Catholic by his mother, Victoria, in 2007.

Kyle died whilst visiting his Scientologist father (Tom Brennan), in Clearwater, in 2007. Kyles father, being a Scientologist, and being apposed Psychological medicine, pilfered Kyles medication and hid it overnight in his truck.

When Tom Brennan returned home that evening, Kyle had shot himself in the head.

Finding his son dead, Tom Brennan called the Church of Scientology and, after a long discussion, they decided to send Jerry Gentile to Toms Apartment.

Jerry Gentile arrived 45 minutes later.

Jerry Gentile is married to Denise Miscavige (the sister of DAVID MISCAVIGE, the Head of the Church of Scientology).

David Miscavige took the decision to call 911 and request an ambulance for Kyle.

This telephone call was made roughly 90 minutes Kyle Brennan was found dead.

Kyle Brennan, like Lisa McPherson before him, was declared Dead on Arrival at hospital.

The Clearwater Police found Kyles medication hidden in Tom Brennans truck the next day.

Kyle's father was more concerned with protecting the interests of the Church of Scientology that he was of saving his son's life.

He was also guilty of negligent homicide by depriving his son of his medication.

If you want to protest about Kyles murder by Tom Brennan, Jerry Gentile, David Miscavige and the Church of Scientology,

If you are outraged by the circumstances of Kyle's death, please express your disgust to the following authorities:

Attorney Luke Lirot,

2240 Belleair Road, Suite 190,


Florida 33764.

Steven E. Ibison,

Special Agent in Charge,

FBI Tampa,

525 West Gray Street,

Tampa, Florida 33609.

Bernie McCabe,

State Attorney,

Sixth Judicial Circuit,

Pinellas & Pasco Counties,

PO Box 5028,


FLORIDA 33758.

Miscavige sister advised taking Lexapro off youth who shot himself to death next day ..FIDDAMAN danger exposed

Mom sues Church of Scientology in son's death

St. Petersburg Times/February 17, 2009

By Jonathan Abel

Clearwater - A mother has filed a wrongful death lawsuit against the Church of Scientology, its Flag Service Organization and three parishioners, claiming they brought about her son's death by denying him access to his antidepression medication.

Among the three parishioners named as defendants: Denise Gentile, the twin sister of the church's current worldwide leader, David Miscavige, as well as her husband, Gerald Gentile.

The lawsuit stems from the death of Kyle T. Brennan, 20, who shot himself in the head on Feb. 16, 2007, in Clearwater, while visiting his father, who is a Scientologist.

Police determined the death was a suicide, but Victoria Britton, the young man's mother, said Scientologists are responsible.

Filed in Tampa federal court Friday, the lawsuit claims Gentile and her husband persuaded Kyle Brennan's father to take away his Lexapro, which his son was taking for depression and anxiety.

The suit, which also names Thomas Brennan as a defendant, states that the defendants tried to put Kyle Brennan into a Narconon drug treatment program.

Kyle Brennan was not a Scientologist, the suit states.

The suit is being brought by attorney Ken Dandar, well-known for his extended legal battle against Scientology during the Lisa McPherson case. McPherson, a 36-year-old Scientologist, died in 1995 while in the care of church staffers in Clearwater.

Scientology spokesman Tommy Davis said the lawsuit is an attempt to "draw the church into something that we don't have anything to do with."

None of the Scientologists named as defendants were church staff members, he said. They were all just parishioners. And Davis emphasized that the events took place on private property without church involvement.

Even Narconon, the drug treatment program that uses L. Ron Hubbard's teachings, is a separate entity from the Church of Scientology, he said.

Still, the case draws attention to Scientology's opposition to psychiatric drugs like Lexapro, which it deems to be mind-altering.

The Web site for Lexapro warns users not to go off their medication suddenly, even if they are feeling better. Changes in dosage, it says, can cause patients on antidepressants to worsen their depression, show signs of mood changes and exhibit thoughts of suicide.

Before his death, Kyle Brennan lived at home in Charlottesville, Va., where he was attending college, Dandar said. He was in the second year of a liberal arts degree when he left school and traveled around the country, Dandar said.

Kyle Brennan made a number of stops, going as far west as Hawaii, but in February 2007 he found his way to Clearwater, to stay with his father, whom he hadn't seen since the summer before.

Dandar said Kyle was taking a 10 mg dose of Lexapro, which he descried as "moderate." It was prescribed for him in early 2006 to help him with depression and anxiety.

He continued to use the drug while staying in his dad's two-bedroom apartment at 423 Cleveland St. in Clearwater, Dandar said.

But a week into the stay, Denise Gentile and her husband prevailed upon Kyle's father to take away the Lexapro medication and lock it in his truck, the lawsuit alleges.

While Scientology spokesman Davis said Denise Gentile was not in any authority position at the church, the suit alleges she had the title of "chaplain" and was held up as an authority of sorts on helping families with emotional matters.

The Gentiles and Brennan also phoned Britton, the young man's mother, to try to persuade her to put Kyle in Narconon, the lawsuit states.

The mother, who is not a Scientologist, was adamant that she and her son did not want anything to do with the drug treatment, the lawsuit states. She insisted that her son be put back on Lexapro.

The medication remained locked away, the suit states.

On Feb. 16, 2007, just after 11 p.m., Kyle Brennan shot himself with a loaded .357 Magnum that he found in his father's apartment, the lawsuit states.

His father found him dead, his head slumped in a laundry basket.

The lawsuit said it is unclear how he got ahold of the gun, but it blames "one or more of the Defendants."

"They locked up his medicine, but not the loaded .357 Magnum. That's the story line," Dandar said. "I think that's the case."

Thomas Brennan did not return a phone call left on his voice mail. Neither Denise nor Gerald Gentile could be reached for comment.

SCIENTOLOGISTS took antidepressants off youth who then shot himself to death next day

Scientologists Aren't Liable for Suicide of Young Man



(CN) - The mother of a boy who killed himself cannot sue his father and the Church of Scientology for taking away his antidepressants, a federal judge ruled.

Victoria Britton filed suit in 2009 over the death of her 20-year-old son, Kyle Thomas Brennan, after he visited with his father in Clearwater, Fla., in February 2007.

Kyle Brennan had allegedly been the victim of an assault days earlier, but he was taking Lexapro antidepressants consistently.

Concerned that his son was suicidal, Thomas Brennan, a Scientologist, contacted a counselor with church, according to the complaint. But the Thomas' auditor with the church, Denise Gentile, allegedly advised him to take his son's medication away even though Kyle was not a Scientologist himself.

Less than 24 hours after taking away Kyle's antidepressants, the young man "was dead from a single shot of a 357 magnum handgun inside the father's bedroom," according to the complaint.

Kyle's psychiatrist allegedly said that stopping the antidepressants so abruptly, coupled with Kyle knowing he could not have them, exasperated his mental condition.

The defendants Britton had sued - the Church of Scientology Flag Service Organization, Denise Gentile, Gerald Gentile and Thomas Brennan - moved for summary judgment last year, claiming a lack of evidence.

U.S. District Judge Steven Merryday granted that motion on Dec. 6, noting that Kyle had contacted more than 24 governmental agencies to initiate criminal proceedings against most of his immediate family before arriving at his father's home.

"The record is clear that Kyle soon relinquished his Lexapro to his father, who is the sole source of testimony about the attendant circumstances," Merryday wrote. "The father reports that Kyle - acting unilaterally and voluntarily - presented the Lexapro to his father and said, 'I hate this shit. It makes me sick.' Kyle's father claims he took the Lexapro to a local library, researched the pharmacology of Lexapro, and placed the Lexapro in the trunk of his car. No other direct evidence or permissible inference describes the circumstances of Kyle's surrendering the Lexapro to his father."

Britton had claimed the "smoking gun" of her case was a communication from Gentile's supervisor, who said, "Get your son moved out and get him set up somewhere so that he can be handled,"

Merryday disagreed. "This entry shows that an ethics officer within Scientology advised an active practitioner of Scientology to move a troubled non-Scientologist from the practitioner's residence and to somewhere that assistance was available for the non-member," he wrote. "No evidence exists that anything at all occurred as a result of this entry, no evidence exists that Denise Gentile did anything because of this entry, no evidence exists that Kyle's father did anything because of this entry, and no evidence exists that anything either happened or failed to happen to Kyle because of this entry."

"The plaintiff's tendered explanation of the meaning of the term 'handled' within Scientology adds little or nothing to support the plaintiff's extravagant claims," he added.

The Church of Scientology is not responsible for Kyle having access to a handgun, Merryday found.

"No evidence suggests that Scientology or the Gentiles knew of the handgun in even the remotest manner or had reason to suspect the presence of the handgun in the father's apartment," the 24-page decision states. "Both Scientology and the Gentiles are in this record utterly unconnected to the handgun and the ammunition."

Merryday said that "a close and objective examination of the extensive record developed in this action confirms the soundness of the defendants' attack on the plaintiff's claim."

"The plaintiff's claim of Scientology's complicity in, and responsibility for, Kyle's death remains a mere hypothesis that is without essential support based upon reasoned and direct inference from the available evidence," he added. "In particular and in a manner fatal to the plaintiff's claim, the available evidence leaves irreparable gaps in the plaintiff's proposed historical sequence and irreparable gaps in the causal relation between persons and events and their respective consequences."

SSRI campaign - calling all the shots, Doyle Mills the FIDDAMAN puppet master

DOYLE MILLS dining out on the vulnerable who were initially shafted by their doctors, exploited by pHARMa and finished off by Scientology, their criminal laylers and stooges like FIDDAMAN

check out -

Scientology's LEAF Project Letters to the Editor (link)

FIDDAMAN - - Laraine Shape - SCIENTOLOGY ordained minister, assistant guardian ...

Friday, 23 December 2011 = = Laraine Shape = Scientology

domain whois -

Registrar: FastDomain Inc.

Provider Name....: BlueHost.Com

Provider Whois...:

Provider Homepage:


Created on..............: 2011-11-16 21:36:00 GMT

Expires on..............: 2012-11-16 21:36:00 GMT

Last modified on........: 2011-11-16 21:36:00 GMT

Registrant Info: (FAST-16675130)
Laraine Shape
905 Franklin Rd. #8
Lebanon, Ohio 45036
United States
Phone: +1.3216986405

Last modified: 2011-11-16 21:36:00 GMT

Laraine Shape in Scientology's Published Service Completion Lists

The following 7 individual completions for Laraine Shape appear in official Scientology publications:

Laraine Shape PTS/SIP COURSE PART ONE Source 64 1988-11-01

Laraine Shape HUBBARD SOLO AUDITOR COURSE PART TWO Source 69 1989-12-01

Laraine Shape ELIGIBILITY FOR ISSUE OF OT LEVELS CHECK Source 69 1989-12-01

Laraine Shape OT II Source 69 1989-12-01

Laraine Shape OT III Source 69 1989-12-01

Laraine Shape FALSE PURPOSE RUNDOWN AUDITING Source 69 1989-12-01

Laraine Shape NEW OT IV OT DRUG RUNDOWN Source 80 1992-05-01

Abnormality in auditory processing underlies dyslexia ....interesting post on FIDDAMAN counterpoint blog

Abnormality in auditory processing underlies dyslexia

December 21st, 2011 in Neuroscience

People with dyslexia often struggle with the ability to accurately decode and identify what they read. Although disrupted processing of speech sounds has been implicated in the underlying pathology of dyslexia, the basis of this disruption and how it interferes with reading comprehension has not been fully explained. Now, new research published by Cell Press in the December 22 issue of the journal Neuron finds that a specific abnormality in the processing of auditory signals accounts for the main symptoms of dyslexia.

"It is widely agreed that for a majority of dyslexic children, the main cause is related to a deficit in the processing of speech sounds," explains senior study author, Dr. Anne-Lise Giraud and Franck Ramus from the Ecole Normale Supérieure in Paris, France. "It is also well established that there are three main symptoms of this deficit: difficulty paying attention to individual speech sounds, a limited ability to repeat a list of pseudowords or numbers, and a slow performance when asked to name a series of pictures, colors, or numbers as quickly as possible. However, the underlying basis of these symptoms has not been elucidated."

Dr. Giraud and colleagues examined whether an abnormality in the early steps of auditory processing in the brain, called "sampling," is linked with dyslexia by focusing on the idea that an anomaly in the initial processing of phonemes, the smallest units of sound that can be used to make a word, might have a direct impact on the processing of speech.

The researchers found that typical brain processing of auditory rhythms associated with phonemes was disrupted in the left auditory cortex of dyslexics and that this deficit correlated with measures of speech sound processing. Further, dyslexics exhibited an enhanced response to high-frequency rhythms that indirectly interfered with verbal memory. It is possible that this "oversampling" might result in a distortion of the representation of speech sounds.

"Our results suggest that the left auditory cortex of dyslexic people may be less responsive to modulations at very specific frequencies that are optimal for analysis of speech sounds and overly responsive to higher frequencies, which is potentially detrimental to their verbal short-term memory abilities," concludes Dr. Giraud. "Taken together, our data suggest that the auditory cortex of dyslexic individuals is less fine-tuned to the specific needs of speech processing."

Provided by Cell Press

"Listen up: Abnormality in auditory processing underlies dyslexia." December 21st, 2011.

Thursday, 22 December 2011

MHRA breast implands - regulator "mauled" by castrated kitten Mark Harvey of Hugh James Seroxat & FIDDAMAN fame

Implants row lawyers slam regulator -

(UKPA) – 41 minutes ago

Lawyers acting for women who are suing UK clinics over health concerns linked to breast implants have launched a stinging attack on the medical regulator.

They accused the Medicines and Healthcare products Regulatory Agency (MHRA) of failing to take action to deal with complaints and for dismissing serious health problems linked to the devices.

More than 270 women in the UK intend to sue those clinics where they underwent surgery to be fitted with the implants, manufactured by French company Poly Implant Prostheses (PIP), which has now closed.

Lawyers say the number of complainants is growing rapidly and they have lodged class action cases.

The implants have been linked to the death of a French woman from a rare form of cancer called anaplastic large cell lymphoma, and are implicated in another seven or eight cancer cases. They are filled with an unapproved non-medical grade silicone believed to be made for mattresses and there have been reports that the protective barriers are faulty.

French authorities are expected to formally announce on Friday that up to 30,000 women who received the implants in France can have them taken out. But UK regulators have insisted there is no link with cancer and there is no need for women to have them removed.

Figures from the MHRA suggest 84,300 PIP implants have been sold in the UK since 2001. Based on the assumption that each woman has two implants, at least 42,000 women in the UK could be affected, according to the MHRA.

But the figure could be higher because women undergoing breast reconstructive surgery following cancer may only have had one implant.

Mark Harvey, a partner at Hugh James solicitors, which is representing more than 250 women, said some of his clients had complained of inflammation, fatigue and fibromyalgia, a musculoskeletal pain disorder.

In a statement, Mr Harvey added: "The recent reports have, of course, been very worrying to our clients, many of whom have already suffered terrible problems as a result of their implants. I have written again to the MHRA to urge them to react to the developments in France and, similarly to France, to set up a suitable protocol for women affected in this country."

Copyright © 2011 The Press Association. All rights reserved

Wednesday, 21 December 2011

Doctors walk away from FIDDAMAN Scientology CCHR group - unbearable, suppressive, stifling, unethical

A recognized doctor in the Bob Fiddaman group is rumored to have had to "walk away" from Bob Fiddaman & CCHR. "We communicate less frequently."He found them unbearable, suppressive, stifling, unethical. He is also certain Bob Fiddaman has lied about the twitter pages he claims not to be administrator of. "I didn't sign up for that."

read more here LINK

Monday, 19 December 2011

A depressing picture - lack of alternative therapy rather than pHARMa influence ?

New figures I have obtained under freedom of information paint a troubling picture of the mental well-being of people in part of Wales and northern England.

It may be the recession, but I suspect the statistics showing very high levels of anti-depressant use in those regions have more complex origins.

The new numbers also show yet another increase in prescribing pills like Prozac, despite national guidance advocating alternative treatments - up 3.15% in Wales and 3.64% in England during 2008.

The previously unpublished data, given to me by the Prescription Pricing Authority in England and the Prescribing Services Unit in Wales, focus on January this year. If one looks at the number of prescriptions for anti-depressants issued in that month per thousand patients, a startling story emerges.

The top seven are all Welsh Local Health Boards (LHBs) in a small area in the south of the country. Of the top thirty prescribers, 12 are in Wales and 10 are Primary Care Trusts (PCTs) in the north-east of England.

We even see a local health authority prescribing at a rate greater than one prescription for 10 patients. In Torfaen, the area around Pontypool in south Wales, GPs handed out 104 prescriptions per 1,000 patients during January. This appears to be an astonishing level of anti-depressant use. GPs we have contacted blame a shortage of counselling for the high prescribing levels.
Both south Wales and the north-east of England are areas with high levels of people not in work, but deprivation cannot explain what one sees as the other end of the table. Of the 30 PCTs which have the lowest levels of anti-depressant prescribing, all but two are in Greater London. And these areas include some of the most deprived in England

The figures also show how January 2009 compares with January 2008, and I wondered whether this might reveal the effects of the recession. The map shows a less obvious regional picture.

The biggest year-on-year increases in prescribing are both in south Wales: Torfaen has seen a rise of over eight prescriptions per 1,000 patients in twelve months, consolidating its position at the top of the table.

Blaenau Gwent, Bridgend and Neath/Port Talbot have also seen very large rises. Six of the top 20 places ranked by the increase in prescribing anti-depressants are in Wales. Have free prescriptions made a difference? If so, why do figures for the Vale of Glamorgan and Wrexham show falls in anti-depressant use?

In England, Swindon and Sunderland, which have both recently seen big job losses and lay-offs as a result of the economic downturn, have seen anti-depressant prescriptions rise by more than five prescriptions per 1,000 patients.

Tameside and Glossop sees the largest increase in the past 12 months in England with at least one local doctor saying that the recession is having a serious effect on the area's mental health.

I have no doubt that the threat and impact of recession is having a psychological effect upon many people in the UK - but anti-depressant prescribing has been rising for years and, in fact, the rate of increase is falling. Comparing Jan 2007 with Jan 2008, the increase in England was 8.3%, and it was 9% in Wales.

Friday, 16 December 2011

FIDDAMAN Fails again as Health Canada Approves Abilify® as First Atypical Antipsychotic in the treatment of Adolescents with Schizophrenia

Health Canada Approves Abilify® as First Atypical Antipsychotic in the Treatment of Adolescents with SchizophreniaOne-third of people living with schizophrenia experience a psychotic episode by age 19

MONTREAL, Dec. 16, 2011 /CNW/ - Health Canada has approved Abilify® (aripiprazole) for the treatment of schizophrenia in adolescents age 15 to 17, making it the first atypical antipsychotic to be specifically approved for this use in this patient population. Abilify was first approved in 2009 for the treatment of schizophrenia and Bipolar I disorder in adults.

Schizophrenia is a serious, complex and life-altering mental illness where people experience psychosis or trouble sorting out what is real and not real. They may hear voices that aren't there or become paranoid. About one third of those living with the disease experience their first psychotic episode by age 19.1 Treatment is an important aspect of managing this disease and can help a young adult with schizophrenia recover to become functional and live a personally and socially satisfying life.

"Adolescence is a critical time in a person's emotional, social and academic development," explains Dr. Thomas Hastings, Lead Psychiatrist for the Halton Region Early Intervention in Psychosis Program. "When schizophrenia develops in adolescence the impact on these areas can be profound. We know that early, accurate, diagnosis and comprehensive and effective treatment gives people with schizophrenia the best chance for successful management of this condition. As such, today's news is very important for teens with schizophrenia, as well as their families."

In adolescents, schizophrenia can be hard to recognize and diagnose, especially in its early stages when symptoms are less pronounced. A complicating factor is that substance abuse is often present when psychotic symptoms appear and needs to be ruled out as the cause of these symptoms.

A greater proportion of males with schizophrenia are first affected in adolescence, with 39 per cent of males and 23 per cent of females having their first psychotic episode by age 19.2 Treatment of schizophrenia remains difficult - over 40 per cent of sufferers stop taking their medication within the first year.3

Louise's story

"Growing up was very difficult for me," explained Louise, a 29-year-old Canadian who currently uses Abilify, and whose name has been changed to respect her privacy. "I was diagnosed with adolescent schizophrenia 14 years ago and my prognosis was bleak. I was told I would never work, finish school or have a normal life."

Louise was hospitalized 13 times for her condition, her shortest hospital visit lasting three weeks and the longest six months. She was put on an anti-psychotic drug resulting in her being "stable enough to be home, but not a productive member of society."

In 2008, she started treatment with Abilify through a special access program and began feeling better after only a few weeks. "Since my diagnosis, I had heard voices every minute, and then within two months the voices were gone. I've also lost 80 pounds since starting Abilify, and I don't sleep 15 hours a day anymore."

Louise's condition over the past three years has improved to the point that she is now working in a shop, selling and working with customers. "I love it," she said. "I've even gone back to school." She did not want to be identified because many people who know her now don't know about her disease and her past.

Louise is happy to have normal life and wishes the same for others living with schizophrenia. "What I want is for teenagers with schizophrenia to feel like there is hope and that they are not doomed to live ill."

"We are very pleased that Abilify has received Health Canada approval for adolescent use," said Chris Summerville, CEO of the Schizophrenia Society of Canada. "It is important recognition of the impact of schizophrenia on young people and we hope it will lead to greater awareness, earlier diagnosis and earlier use of effective treatment."

About Abilify in adolescents

Abilify is the first and only medication in Canada approved to treat schizophrenia in adolescents 15 to 17 years of age. The approval is based on the results of a 6-week, double-blind randomized, placebo-controlled trial published by Findling et al (Study 31-03-239).4 This trial showed statistically significant differences with Abilify 10-mg and 30-mg compared to placebo with improvements in the mean change from baseline to endpoint on the primary efficacy measure, the Positive and Negative Syndrome Scale (PANSS) total score, and on other measures. Abilify treatment was generally safe and well tolerated.5 It offers effective control of the symptoms of schizophrenia associated with social functioning and has been shown to have a good safety and tolerability profile. Abilify improves symptoms such as hallucinations and delusions, and positively impacts functional ability, such as a lack of motivation or social withdrawal.

About Abilify

Abilify (aripiprazole) was the first third-generation antipsychotic medication approved in Canada. It is available by prescription only. It has been approved by Health Canada for the treatment of schizophrenia and related psychotic disorders in adults and for the treatment of schizophrenia in adolescents 15 to 17 years of age. It is also indicated for the treatment of manic or mixed episodes in bipolar I disorder in adults as acute monotherapy or co-therapy with lithium or divalproex sodium when there is an insufficient acute response to these agents alone. Abilify as co-therapy with lithium or divalproex sodium has been shown to be more effective than placebo plus mood stabilizer in maintaining clinical improvement for up to one year in adult patients with manic or mixed episodes associated with bipolar I disorder.

About Bristol-Myers Squibb Canada

Bristol-Myers Squibb Canada is an indirect wholly-owned subsidiary of Bristol-Myers Squibb Company, a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. Bristol-Myers Squibb Canada is a leading provider of medicines to fight cancer, cardiovascular and metabolic disorders, infectious diseases (including HIV/AIDS), nervous system diseases and serious mental illness. Bristol-Myers Squibb Company is listed on the New York Stock Exchange under the BMY symbol (NYSE:BMY). Bristol-Myers Squibb Canada's operations are headquartered in Montréal, Québec.

Abilify® is a trademark of Otsuka Pharmaceutical Co., Ltd. used under license by Bristol-Myers Squibb Canada.

Antidepressant Mirtazapine not accepted as blame in murder trial ...check FIDDAMAN counter blog first with the truth

WEST PALM BEACH — A jury on Monday convicted 83-year-old Alfred Infosino of second-degree murder for beating his 77-year-old girlfriend to death with a flashlight.

The verdict came at the end of a weeklong first-degree murder trial for Infosino, whose attorneys tried to convince jurors he was suffering side effects from an improperly prescribed antidepressant drug when he awoke at 4 a.m. and attacked his longtime partner, Rita Chirel, inside the home they shared in suburban Delray Beach.

In closing arguments, Assistant State Attorney Andrew Slater played parts of the 911 call Infosino made hours after the October 2010 killing. In it, Infosino gruffly explained to the operator that he had killed Chirel and drank ammonia in an attempt to kill himself.

Infosino called his brother to express shame over what he had done and scrawled a letter Slater called "a perfect act of contrition," two signs Slater said meant that he knew what he was doing was wrong at the time of the attack.

Slater said Infosino, a former New York attorney who had recently lost a position of power in his homeowners association, simply failed to restrain his temper.

"This is a man whose life had fallen down around him. He's not the president, he's not the big cheese in the community that he used to be and he couldn't take it," Slater said. "It's no more complicated than that."

But Infosino's attorney Michael Schutt told jurors that the only thing that could explain Infosino's actions on the morning he killed Chirel was the culmination of disturbing side effects from the antidepressant, Remeron, also known as Mirtazapine.

Schutt described for jurors how the drug had transformed Infosino from a mildly depressed octogenarian into a paranoid, deeply disturbed man who suddenly thought the woman he described as "his life" was trying to poison him, steal his money and drive him crazy.

"Why would he beat to death the woman he loved, the woman he wanted to spend the rest of his life with?" Schutt asked jurors before adding of Infosino: "He had nothing to gain, and everything to lose with Rita dead."

Jurors began deliberating the case just after 2 p.m. and returned the verdict two hours later. Infosino faces up to life in prison when he is sentenced Dec. 21.

Schutt, who told jurors that Infosino could barely muster the energy to stay awake during his trial, said he disagreed with the panel's verdict. He and Assistant Public Defender Jennifer Marshall said though Infosino was mentally strong enough to understand that he had been convicted, his health is otherwise poor.

"His body's breaking down, he's got a terrible heart. He's dying," Schutt said.

Thursday, 15 December 2011

Post Cervarix Syndrome Victim: Brianna ..helped by ANTIPSYCHOTIC Stemetil mad article or what FIDDAMAN

"....called the doctor again the following Monday, 31st October 2011. This time she told us to come in to see her. She requested a urine test and gave Brianna a thorough examination (she had a high temperature again) and prescribed Stemetil to help with the nausea – this does really help. "

check out the link  Stemetil Prochlorperazine (Compazine, Stemzine, Buccastem, Stemetil, Phenotil) is a dopamine (D2) receptor antagonist that belongs to the phenothiazine class of antipsychotic agents that are used for the antiemetic treatment of nausea and vertigo. It is also a highly-potent typical antipsychotic, 10-20x more potent than chlorpromazine. It is also used to treat migraine headaches. Intravenous administration can be used to treat status migrainosus

Story as told by Brianna’s mum, Laura

Post Cervarix Victim

Brianna is just 13 years old. A girl who was in the top sets at school, represented the school in athletics and has been a dancer since she was the age of 2, performing atLondon’s famous Sadler’s Wells Theatre and the Royal Albert Hall. In more recent years, she developed a love of drama and wants to be an actress when she is older. She is a popular girl, whom people always describe, as being very mature, fun loving and kind.

This was her life until Wednesday, October 19th 2011, exactly 3 weeks after having her first Cervarix vaccine jab at school on Wednesday 28 September. That day, she came home from school complaining of feeling very unwell, nausea being the main symptom. I kept her off school the next day, but on Friday being as it was the last day of term I sent her back. Later in the day, I received a phone call from the Matron saying she had a temperature and was feeling unwell, so could I collect her.

Initially I thought it was maybe connected to her period as she had this the same day. However, by the following Monday she was still feeling the same, nauseous, hot and cold and now also very faint. I called and spoke to our GP, who also thought the symptoms were connected to her period and prescribed some tablets to help with pain and nausea (she did not have any pain).

By now, it was half term week. Every day I attempted to go out with Brianna and her younger brother, but each time we were never out for long before she was begging to go home, as she felt so unwell. The tablets had no affect at all. Once home, she would lie on the sofa and just sleep.

I called the doctor again the following Monday, 31st October 2011. This time she told us to come in to see her. She requested a urine test and gave Brianna a thorough examination (she had a high temperature again) and prescribed Stemetil to help with the nausea – this does really help. All this time, Brianna had continued to feel nauseous, was experiencing hot and cold flushes, and feeling faint, dizzy, lethargic and generally unwell. It did not appear to be improving. We went back to the GP on Thursday when it was confirmed the urine tests were clear. The next step was a blood test, which would also include a check on glandular fever. This was done the next day. Brianna had to be absent from school all of that week.

She went back in to school on the following Monday and Tuesday, but came home quite pale and tired. She cried because the other children laughed at her when her face went red as a result of a hot flush. We returned to the GP on Wednesday for the blood test results which were all clear. By now, Brianna had also started to complain about aching arms and legs and a sore throat coming and going. The GP requested yet another blood test to check her thyroid. This has just been done and we are waiting for the result. She remained off school the rest of the week.

Then only just the other day, it was suggested to me that it could possibly be the HPV vaccine which was causing all these health issues. Something neither of us or the doctor had even considered. Once I started researching, I realised it could very well be the diagnosis as there were just too many similar health reactions being experienced by other girls who had become ill after HPV vaccinations.

Recently, my GP has spoke to GlaxoSmithKline, the vaccine manufacturer. They confirmed that with the exception of the flushes, all her symptoms are known side effects. My GP is now putting in an urgent referral to the Paediatrics at the hospital and will call me soon with the latest blood test results.

Brianna did return to school on Monday. She also went in on Tuesday but was feeling very weak and had a very painful sore throat. By midday the Matron called for me to go and collect her. She is still off school.

She should have received her second injection of Cervarix on the 16th of November 2011, but both her doctor and I agreed that it was not a good idea! Some days are better than others, but we have found the nausea is constant unless she takes her Stemetil. One other interesting thing is that Brianna has had regular annual eye tests and always had perfect vision. However, at her last test (3weeks ago), she was found to be short sighted. Is this another reaction???

Update: Brianna and I have now agreed on a part time schedule with the school, where she just attends the core subjects. However, we are finding that even doing just 2-3 hours at school on one day, makes Brianna feel so ill, and then she cannot attend school the next day – it’s a vicious circle. She is also now experiencing intermittent pain in her legs and arms, in particular, near the site of the injection. All her blood tests have come back clear and I have been advised that we have an appointment with the paediatrician on 13th December 2011.

Yesterday (2nd December 2011), I spoke to the matron about some hurtful comments other children were making when Brianna was in school e.g, “why aren’t you dead yet Brianna?” I am sure you can imagine how upsetting this was to both Brianna and me. The matron was disgusted and is going to speak to the pupils about how you should respect that people are unwell and not be nasty, in a forthcoming school assembly, without being specific about Brianna. As if my lovely daughter does not have enough to put up with without having to listen to these terrible comments that are being said about her

We will never give up. We will continue fighting in our daughter’s corner and do all in our power to make certain those in authority are aware of the damage that is happening to many young girls throughout the UK.

Monday, 12 December 2011

Failed car assembly worker FIDDAMAN can't tell an antipsychotic from a amphetamine

fiddaman said - So, let's get this straight. A 6 year old is given a flu jab, he has an adverse reaction to it, a reaction that is so horrendous that he sleeps for most of the day, his school even allow him to take a nap. To combat this, young Josh is given a powerful antipsychotic and, according to the Mail Online, antidepressants, medication that has not been recommended for use in children.

Friday, 9 December 2011

Fiddaman requested MHRA meet GSK researcher Prof David Healy

Prof David Healy proudly admits he worked for GSK GlaxoSmithKline who pay him the most - FIDDAMAN counterpoint blog

After first writing about Prozac induced problems in the early 1990s, Lilly offered me a consultancy with the company. I incorporated statements to this effect at the end of articles and have letters from 1995 from plaintiffs' lawyers in Prozac cases who said they would never have consulted me if they had known of my prior links to Lilly.

At that time and subsequently I was involved in clinical trials for and was a speaker for SmithKline Beecham, the makers of the SSRI Paxil, and the largest amount of funding from pharmaceutical company sources that I have received to date has come from that source, and not from Pharmacia.

source - -----Original Message-----

From: David Healy
Sent: Sunday, November 02, 2003 6:35 PM
To: Vera Sharav; Vera Sharav
Subject: i know carl elliot

location -

Prof David Healy outlines his work for pHARMa in his own words - FIDDAMAN & Scientology misrepresents

extract -

Some testimony under oath in Cassidy v Eli Lilly, taken in Chicago, on November 21, 2001, under questioning from A See, attorney for Lilly, might be of use here. I have left the text complete with redundancies

See: You have served as a consultant to Pharmacia and Upjohn regarding their antidepressant reboxetine?

H: Yes, I have.

See: You have done clinical work for them?

H: No, I have done no clinical trials. I have served as a consultant for them. I have been a speaker for them, but done no clinical work.

See: You have gone to speak in front of peer groups?

H: Yes.

See: About Reboxetine?

H: I primarily talked about the role of the drug acting on the [norepinephrine] system in the case of people who were depressed.

See: And it happens that that's the way reboxetine works?

H: Absolutely, yes.

See: And you have been compensated for that?

H: I have indeed.

See: Did you perform that work at the request of Pharmacia and Upjohn and your receipt of compensation from them for performing education functions and so on, did that make you a biased person?

H: I'm sure that the receipt of funds from Pharmacia and Upjohn as well as the receipt of funds from Lilly and SmithKline and others has biased me, yes. I think some sort of bias is inevitable. It is an issue of trying to manage that bias.

Thursday, 8 December 2011

David Healy - received substantial fees from Pharmacia, the manufacturer of reboxetine - FIDDAMAN counterpoint blog

I know Carl Elliot well, am a friend of his, and reviewed his latest book in the current edition of AJOB. I have read everything he wrote about Healy. He is wrong, and if you knew more about the Healy case than just what is in Carl's article, you would know that Healy utterly misrepresented himself and has since retracted almost everything he claimed. He has recently admitted, for example, that he received substantial fees from Pharmacia, the manufacturer of reboxetine, as well as other Big Pharma that he never disclosed to the Hastings Center Report (as he promised to do) or any other venue during his "victimization." He also now says that Lilly DID NOT influence the rescinding of his offer (this is Healy talking, not Lilly). You would hardly believe his latest "personal disclosure" statement in an article he recently published:

read in full -

Dr. Healy has been an expert witness for defense on a series of LSD and ECT cases - FIDDAMAN counterpoint blog

Dr. Healy has been an expert witness for the plaintiff in five legal actions involving SSRIs and has been consulted on a number of other attempted suicide, suicide and suicide-homicide cases following antidepressant medication, in the majority of which he has offered the view that the treatment was not involved. Dr. Healy has also been an expert witness for the defense on a series of LSD (46) and ECT (1) cases

read in full link

Dr David Healy defends this - 

List of pharmaceutical companies Dr. Healy has had consultancies with - FIDDAMAN counterpoint blog

In recent years Dr. Healy has had consultancies with, been a principal investigator or clinical trialist for, been a chairman or speaker at international symposia for, or been in receipt of support to attend meetings from: Astra, Astra-Zeneca, Boots/Knoll Pharmaceuticals, Eli Lilly, Janssen-Cilag, Lorex-Synthelabo, Lundbeck, Organon, Pharmacia & Upjohn, Pierre-Fabre, Pfizer, Rhone-Poulenc Rorer, Roche, SmithKline Beecham, Solvay, and Zeneca.

source -

From: Paul Root Wolpe

Sent: Tuesday, October 28, 2003 4:30 PM


Subject: Re: Ethics of U Penn surgical "drug implant" experiment


We will have to agree to disagree, so this will be my last email on this. A few reactions:

I have tried to "personalize" our disagreement? Allow me to quote the email that started all this:

At 5:00 PM -0400 10/7/03, VERACARE wrote: one of Penn's senior fellows at the Center for Bioethics, Paul Root Wolpe, PhD, who is Director of Psychiatry and Ethics at the School of Medicine. Given that bioethicists are not free of financial conflicts of interest, having close ties to the biotech / drug industry, the unacknowledged purpose of such discussions is, no doubt, to pave the way for legitimizing "drug implant" technology "by consensus"--a favorite method for pushing through dubious public policies.

So please, when you use innuendo that impunes my motives and career, using common rhetorical devices like "no doubt" which are substitutes for any actual substantiation of claims, please don't accuse ME of insisting on personalizing this.

I know all about psychiatric drugs. I have also seen people in major depression and floridly psychotic. I, like so many of them, would choose the meds over killing myself or living the tortured life of the schizophrenic. You can quote all you want people who object to psychiatric meds, and I would be happy to quote back as many experts who think they are godsends. The point is that I believe people should have a choice. This technology is simply one more choice.

I know Carl Elliot well, am a friend of his, and reviewed his latest book in the current edition of AJOB. I have read everything he wrote about Healy. He is wrong, and if you knew more about the Healy case than just what is in Carl's article, you would know that Healy utterly misrepresented himself and has since retracted almost everything he claimed. He has recently admitted, for example, that he received substantial fees from Pharmacia, the manufacturer of reboxetine, as well as other Big Pharma that he never disclosed to the Hastings Center Report (as he promised to do) or any other venue during his "victimization." He also now says that Lilly DID NOT influence the rescinding of his offer (this is Healy talking, not Lilly). You would hardly believe his latest "personal disclosure" statement in an article he recently published:

In recent years Dr. Healy has had consultancies with, been a principal investigator or clinical trialist for, been a chairman or speaker at international symposia for, or been in receipt of support to attend meetings from: Astra, Astra-Zeneca, Boots/Knoll Pharmaceuticals, Eli Lilly, Janssen-Cilag, Lorex-Synthelabo, Lundbeck, Organon, Pharmacia & Upjohn, Pierre-Fabre, Pfizer, Rhone-Poulenc Rorer, Roche, SmithKline Beecham, Solvay, and Zeneca. Dr. Healy has been an expert witness for the plaintiff in five legal actions involving SSRIs and has been consulted on a number of other attempted suicide, suicide and suicide-homicide cases following antidepressant medication, in the majority of which he has offered the view that the treatment was not involved. Dr. Healy has also been an expert witness for the defense on a series of LSD (46) and ECT (1) cases.

Again, that is Healy himself disclosing, admitting that in the majority of cases he testifies that SSRIs are not involved. In other words, the story Carl told about Healy, and the story Healy USED to tell about himself, are patently false.

You say i do not appreciate the significance of Healy and Olivieri; of course I do, especially Olivieri, who I lecture about to medical students. But they are clinical researchers; that is the point you have consistently refused to address. Pharma has a hold over them that is simply does not have over bioethicists. Which does not say that some biothicists are not influenced by Pharma. Of course they are. What it does say is the other point I have made over and over and that you have never responded to: the fact that "bioethicists" can be influenced by drug money does not mean that I am, any more than the fact that "patient advocates" can be influenced by drug money means that you are. And it is just ridiculous to say that, because a clinical researcher asked Art for a recommendation that he took, that Art therefore "does clinical trials." I mean, really. If the researchers decide not to use these implants on people because they read your CIRCARE column, are you then a clinical researcher?

The problem, Vera, is that you will just lump together any political issue that you think makes your ideological point; you simply obscure the differences between "bioethicists" and a particular bioethicist, or someone who gives advice to a clinical researcher and someone who does clinical research.

And if my insistence in using "scratched" to describe what hte monkey did (the word the researchers who were there used, by the way) is ideological, than your insistence on using the words "rip through his chest to yank the implant out" is equally ideological. I, at least, heard what happened from the people who were there, and use their description. You just make up the most emotionally volatile words you can think of as scare tactics.

And, finally, you misrepresent who is targeted by the researchers. There are many psychiatric patients who miss taking their meds for many reasons, not just because they "choose" not to take them. Patients come to doctors asking for ways to make sure they take their meds; that is why the two week injections that are offered now are very popular among patients.


* * * *

Paul Root Wolpe, Ph.D.

Departments of Psychiatry and Sociology

and Center for Bioethics

University of Pennsylvania

Chief of Bioethics

(Care and Protection of Research Subjects and Patients)

National Aeronautics and Space Administration (NASA)

Center for Bioethics:

3401 Market St., Suite 320

Philadelphia PA 19104

(215) 573-9378 or 898-7136

(215) 573-3036 (fax)

Wednesday, 7 December 2011

PROZAC child murderer - history of smoking marijuana and “experimented” with cocaine - just like Sarah Carlin FIDDAMAN

The Winnipeg murderer had a history of smoking marijuana, had abused prescription drugs and “experimented” with cocaine,

read in full
A Winnipeg judge’s ruling that a teenage boy murdered his friend because of the effects of Prozac will not be appealed, confirming an apparent North American first and reviving debate around the widespread prescription of anti-depressants to young people.

Justice Robert Heinrichs concluded the 15-year-old boy was under the influence of the medication when he thrust a nine-inch kitchen knife into the chest of Seth Ottenbreit, a close friend.

Although the killer pleaded guilty to second-degree murder, the judge cited the drug’s alleged side effects as a reason not to raise the case to adult court, and to mete out a sentence last month of just 10 months – on top of two years already spent in jail.

A spokeswoman for the Manitoba Justice Department said this week prosecutors have decided not to appeal the provincial-court decisions, which were earlier met with outrage from Mr. Ottenbreit’s family and friends.

Both the boy’s lawyer and the psychiatrist who testified on his behalf say it is the first time a criminal-court judge in North America has made such a finding.

Prozac is meant to curb the effects of depression, but Justice Heinrich concluded it set off a steady deterioration in the young murderer’s behaviour.

“He had become irritable, restless, agitated, aggressive and unclear in his thinking,” the judge said. “It was while in that state he overreacted in an impulsive, explosive and violent way. Now that his body and mind are free and clear of any effects of Prozac, he is simply not the same youth in behaviour or character.”

Yet the empirical underpinning of his conclusion, and the pros and cons of young people taking Prozac and other “selective serotonin reuptake inhibitor (SSRI)” anti-depressants, seem less clear-cut.

Justice Heinrichs relied largely on the expert testimony of Dr. Peter Breggin, a controversial American physician known for his outspoken opposition to the use of virtually any psychiatric drug. Some other experts say scientific evidence of a link between the latest anti-depressants and homicide is thin.

“I think it got pulled out of a hat, frankly,” said Dr. Umesh Jain, a child and adolescent psychiatrist at Toronto’s Centre for Addiction and Mental health. “You could construct a weak and biologically plausible effect, but you’d have to be pretty convincing in court.”

Studies have established such drugs can increase the risk of young patients having suicidal thoughts. Their tendency to lift inhibition could also release some hostility or violence lurking in a person’s character, said Dr. Jain. Small studies like one he co-authored in 1992 have also suggested that the drugs can trigger short-term mania, especially in bi-polar disorder patients.

There is little or no scientific evidence directly linking the anti-depressants and serious violence or homicide, though, he said.

Still, the official “product monograph” approved by Health Canada for Prozac says the drugs are not recommended for use on adolescents, and warns that agitation, hostility and aggression might ensue. Doctors are allowed to prescribe medications “off label” to patients even when the approval does not expressly permit it.

Specialists in Winnipeg responded to concerns voiced by the accused’s parents by actually increasing the dose, said Greg Brodsky, the teenager’s lawyer.

“On Prozac he was becoming more irrational and aggressive,” Mr. Brodsky said. “That should have been a warning. That warning wasn’t heeded.”

SSRI drugs have a contentious track record. They were hailed originally as a safe alternative to older anti-depressants, then clinical-trial results came to light in 2004 that suggested they increased the risk of children and adolescents having suicidal thoughts.

Other studies have indicated they are effective in patients with major depression, but little better than a placebo for mild to moderate cases.

The Winnipeg murderer had a history of smoking marijuana, had abused prescription drugs and “experimented” with cocaine, but was trying to break free of that background when a family doctor prescribed Prozac for depression in July, 2009.

On Sept. 20, the accused met with Mr. Ottenbreit and another friend at his house, after the two friends had earlier stormed into his home, allegedly damaging the floor. The killer and Mr. Ottenbreit shared a cigarette, before the accused pulled aside a sweater on the floor of his garage, revealing the knife. He picked it up, “got this weird look on his face,” then abruptly stabbed his friend, the other boy told police.

“They were in my house, they dented the floor, I had nothing else to do but to stab him,” he told police later.

Dr. Keith Hildahl, clinical head of Winnipeg’s Child and Adolescent Mental Health program, testified that the Prozac might have played a role, but concluded on balance that his behaviour that summer was largely a result of the tense relationship he had with his parents.

Dr. Breggin, who has testified in a number of U.S. cases where anti-depressants allegedly led to murder or other violence and reviewed the Winnipeg case, pointed the finger of blame at the medication.

“These drugs produce a stimulant or activation continuum,” he said in an interview. “That continuum includes aggression, hostility, loss of impulse control … all of which are a prescription for violence.”

Dr. Breggin’s long-standing criticism of psychiatric drugs and opposition to the view that psychiatric problems have biochemical roots have prompted some supporters to call him the “conscience” of the speciality, and some psychiatrists and patient advocates to condemn him as a harmful influence.

Dr. Sydney Kennedy, psychiatrist-in-chief at Toronto’s University Health Network, said young people prescribed the drugs should certainly be closely monitored for side effects, but it would be wrong to shy away from using SSRIs on teenagers when necessary.

In fact, a 2007 study found that rates of actual, completed suicides jumped as use of the drugs on young people dropped amid the newfound concerns, suggesting they might have been saving lives before.

“In the large group data, SSRIs do a lot more good than harm,” Dr. Kennedy said.

National Post

Help for Heroes partnership with GSK - read about it on FIDDAMAN counterpoint blog

Help for Heroes partnership

Help for Heroes is a strictly non political and non critical charity that assists and works closely with the Royal Navy, Army and Royal Air Force to provide support where it is most needed. To date, all monies raised for Help for Heroes have spent or allocated on the direct, practical support of Servicemen and women who are wounded, injured or have become sick while in the service of the UK, to include support and assistance to their families when appropriate.

Help for Heroes - 4 Years On

video -

As part of our commitment to promote health and well-being in the communities in which we operate, GSK is supporting the creation of a specialist 'Wellness Centre' at Tedworth House, a Help for Heroes Personnel Recovery and Assessment Centre located in Wiltshire. This support takes the form of a donation of £1 million towards the initial construction and ongoing running of the new centre as well as provision of pro-bono support in the form of know-how, expertise and volunteering opportunities for GSK employees.

At full capacity the Wellness Centre, due to open in mid-2012, will deliver health, sport and exercise programmes to help over 1,000 servicemen and women each year successfully transition back into civilian life.

Visit the Help for Heroes website -

GSK GlaxoSmithKline just can't get enoungh of Bob Fiddaman blog - Help the Heroes

yea ...........they watch this blog in real time

GSK and Help for Heroes partner to support the rehabilitation of wounded servicemen and women in the UK

GlaxoSmithKline plc : GSK and Help for Heroes partner to support the rehabilitation of wounded servicemen and women in the UK

This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates.

Issued: Wednesday 07 December 2011, London UK

GSK and Help for Heroes today announced a new partnership to help support injured British armed forces personnel successfully transition back into civilian life. The partnership will focus on the creation of a specialist 'Wellness Centre' at Tedworth House, a Help for Heroes Personnel Recovery and Assessment Centre located in Wiltshire.

As part of its programme of charitable support in the UK, GSK has pledged to donate £1 million to Help for Heroes over 5 years to be used towards the initial construction and the ongoing running of the new Phoenix Wellness Centre. At full capacity the Centre, due to open in mid-2012, will deliver health, sport and exercise programmes to help over 1,000 servicemen and women each year achieve their individual physical and psychological recovery goals. GSK will also provide pro-bono support in the form of know-how and expertise and will offer GSK employees volunteering opportunities with Help for Heroes as part of a broader partnership between the two groups.

GSK is committed to promoting health and well-being in the communities in which it operates and supports a wide variety of innovative, dynamic charities that help deliver this, such as Help for Heroes.

Andrew Witty, CEO of GSK said: "This new partnership with Help for Heroes will make state of the art rehabilitation facilities available to wounded servicemen and women who deserve our support. GSK is committed to playing its part in helping to improve the health and well-being of communities and we look forward to seeing the completion of the Wellness Centre and to sharing our expertise with Help for Heroes through a long term partnership."

Bryn Parry, CEO and Co-Founder of Help for Heroes said: "Help for Heroes are thrilled to be partnering with GSK. They have already donated an amazing sum of money for which we are hugely grateful and have pledged to continue their support into the future. This support will be invaluable because although the guys and girls are young now, they will grow old and we need to be there to support them for life. Knowing that we have GSK

Saturday, 3 December 2011

CCHR Commissioners what are ? - how to apply & get yourself appointed - for the vain like FIDDAMAN

CCHR Commissioners -

The Citizens Commission on Human Rights® (CCHR) was established in 1969 by the Church of Scientology to investigate and expose psychiatric violations of human rights and to clean up the field of mental healing. Psychiatric “treatment” is severely limited to a paucity of harmful methodologies which depend upon force and which fall primarily into three major categories – psychoactive drugs, electric shock (electro-convulsive therapy or ECT) and psychosurgery.

Civil involuntary commitment of people with insurance assures a ready supply of patients.

The presence of psychiatry has contributed considerably to the rise of unpredictable violence in society. By tracing this unpredictable violence back to the psychiatrists who actually generated the violence through their treatments, criminal action can be expanded to include the criminal negligence of the psychiatrists, who actually are just as guilty as the perpetrator of the act.

Progress has been made. The facts, when uncovered, are too difficult to ignore. CCHR's work in exposing patient abuse, insurance fraud and other forms of psychiatric crime has been acknowledged internationally by politicians, attorneys general, police, health authorities, lawyers and civil rights workers, as well as thousands of victims of psychiatry.

CCHR has Commissioners, members of the group who are authorized to perform various acts or duties.

As a commission of citizens with the task of exposing human rights violations in the field of mental health, we appoint Commissioners who are Opinion Leaders in their respective fields.

These are some of the ways in which a CCHR Commissioner may choose to participate: event speaker, visits to legislators, holding press conferences and media appearances, representing CCHR when meeting with law enforcement or other professional bodies, holding hearings to hear evidence and review documentation of psychiatric abuses and crimes committed, conducting inspections of mental hospitals, presenting findings of psychiatric abuse to legislators and media, and otherwise promoting CCHR and its mission.

Please let us know if you would like to apply to be a Commissioner of CCHR St. Louis.

Professor David Healy tried to sue University of Toronto for $9.4-million - now settles for hanging round FIDDAMAN & Casper

Healy vs. University of Toronto

Scientist stands by views of drugs after settling lawsuit with U of T

A prominent British psychiatrist who found his offer of a post at a University of Toronto teaching hospital rescinded after he criticized a popular form of antidepressants says he stands by his controversial view of the drugs

Healy vs. University of Toronto


Scientist stands by views of drugs after settling lawsuit with U of T

A prominent British psychiatrist who found his offer of a post at a University of Toronto teaching hospital rescinded after he criticized a popular form of antidepressants says he stands by his controversial view of the drugs. Dr. David Healy said he continues to believe that Prozac and other drugs of its class — known as selective serotonin reuptake inhibitors — can be addictive and cause suicidal tendencies in some people.

“My views haven’t changed at all,” said Healy, who recently reached an out-of-court settlement with the university and the hospital, the Centre for Mental Health and Addiction.

“I think the SSRIs can make people suicidal. I think you can get physically dependent on them and can have a withdrawal problem. You may not be able to stop. Full stop.”

Healy, who teaches at the University of Wales, made the comments at a news conference Thursday, his first since he settled his $9.4-million lawsuit against the university and hospital.

The settlement, many of the terms of which remain undisclosed, has resulted in the university offering Healy a visiting professorship which will see him spend a week a year at the University of Toronto for several years, beginning next spring.

Healy launched the lawsuit after the university withdrew in November 2000 a five-year job offer to run the centre’s mood and anxiety program.

“I bore no ill will towards them,” he insisted Thursday. “And clearly the process going on too violently or too long wouldn’t do them any good, wouldn’t do me any good.”

That’s because Healy has other issues he wants to bring to the public’s attention, such as the way drug companies selectively release safety and efficacy data on drugs and use ghost writers to author articles on their drugs for submission to scientific journals.

“And there’s a real hazard that I go on about these things and the legal action was still there, people would say: “Well, we don’t need to pay any heed to that. He’s just saying this because he’s trying to sue the University of Toronto.”

“If I want people to listen to some of the other things, it seemed to be a good idea, (especially) when people on the other side (the university) were being reasonable and weren’t awful people.